Viewing StudyNCT00789828



Ignite Creation Date: 2024-05-05 @ 7:59 PM
Last Modification Date: 2024-10-26 @ 9:57 AM
Study NCT ID: NCT00789828
Status: COMPLETED
Last Update Posted: 2016-02-03
First Post: 2008-11-12

Brief Title: Efficacy and Safety of Everolimus RAD001 in Patients of All Ages With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex TSCEXIST-1
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Subependymal Giant Cell Astrocytoma
Tuberous Sclerosis
Keywords:
Name View
SEGA View
Tuberous Sclerosis View
Subependymal Giant Cell Astrocytoma View
mTOR View
RAD001 View
Mamalian Target Rapamycin View
Everolimus View
TSC View